Notice ID: 8adb6d3eb2e74caf8d09b6244349ca10Special Notice
Drug Discovery and Development consultants for the National Institute on Drug Abuse (NIDA)
Archived on May 25, 2020. Full description on SAM.gov.
Overview
- Posted
- February 7, 2020
- Notice type
- Special Notice
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Last updated
- Sep 25, 2026
Identifiers
- Solicitation number
- 75N95020Q00025
- Notice ID
- 8adb6d3eb2e74caf8d09b6244349ca10
Description
2/7/20 Amendment 01 is posted to provide answers to the questions received from interested vendors. All other terms and conditions of the solicitation remain unchanged. 1/24/20 Solicitation is posted. Please see the attachments for more information.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
No documents available.
Lifecycle
Solicitation:
75N95020Q00025- Combined Synopsis
- Combined SynopsisJan 24, 2020
Drug Discovery and Development consultants for the National Institute on Drug Abuse (NIDA)
- 2×Special NoticeCurrentFeb 7, 2020
Drug Discovery and Development consultants for the National Institute on Drug Abuse (NIDA)
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N95020Q00025
Archive Date
May 25, 2020
Office Address
Bethesda, MD, 20892